Oddo today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and cut its price target to 7600p (from 8000p).

Broker Forecasts data provided by...

China, Italy, UK, GDP, Smiths, Dividends and Supermarkets

“Every little step forward for the markets will help to repair investor confidence following the catastrophic start...

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1530p (from 1830p).

Broker Forecasts data provided by...

Mark Robson, Financial Director, sold 16,454 shares in the company on the 27th March 2020 at a price of 502.70p. The Director now holds 177,450...

Robert Fenwick, Non Executive Director, has transferred in 14,759 shares in the company on the 27th March 2020 at a price of 0.00p. The Director...

Robert Fenwick, Non Executive Director, sold 6,951 shares in the company on the 27th March 2020 at a price of 502.70p. The Director now holds...

Angus Cockburn, Director, has transferred in 11,139 shares in the company on the 27th March 2020 at a price of 0.00p. The Director now holds...

Angus Cockburn, Director, sold 5,247 shares in the company on the 27th March 2020 at a price of 502.70p. The Director now holds 8,490 shares...

Leo Quinn, Chief Executive Officer, has transferred in 47,493 shares in the company on the 31st March 2020 at a price of 0.00p. The Director...

Philip Harrison, Executive Director, has transferred in 23,534 shares in the company on the 31st March 2020 at a price of 0.00p. The Director now...